SCHEMBL634392

SCHEMBL634392

c1ccc(-c2ccc3c4cccc5cccc(c6cccc2c63)c54)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
HPGD P15428 5/20 0.48
HSD17B10 Q99714 5/20 0.48
CYP1A2 P05177 2/20 0.48
THRB P10828 1/20 0.48
ERBB2 P04626 1/20 0.44
FYN P06241 1/20 0.44
MAOA P21397 1/20 0.44
ACHE P22303 1/20 0.44
AHR P35869 1/20 0.44
TNF P01375 1/20 0.43
MAPT P10636 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MPI P34949 1/20 0.41
CDK4 P11802 2/20 0.40
CCND1 P24385 2/20 0.40
L3MBTL1 Q9Y468 4/20 0.39
TSHR P16473 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17242010 0.91 PARP1 (0.43) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL29444814 0.91 PARP1 (0.43) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL2448362 0.91 PARP1 (0.43) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL27803175 0.90 ALDH1A1 (0.45) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL2450835 0.88 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL29444804 0.88 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL15672997 0.85 PARP1 (0.39) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL29789609 0.85 ALDH1A1 (0.50) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL359994 0.85 ALDH1A1 (0.50) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL28840215 0.85 ALDH1A1 (0.50) ALDH1A1HPGDHSD17B10CYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104028308-A Nanometer photo-catalyst used in producing hydrogen by decomposing water under visible light response and application of nanometer photo-catalyst XINJIANG TECH INST PHYSICS CAS 2014-09-10 CN claimed
US-8431051-B2 Organic polymeric photon up-conversion nanoparticles for biological applications SONY CORPORATION (JP) 2013-04-30 US claimed
US-8419985-B2 Polymeric nanoparticles comprising a medium for photon up-conversion SONY CORPORATION (JP) 2013-04-16 US claimed
EP-2075304-B1 A DEVICE FOR MODIFYING THE WAVELENGHT RANGE OF A SPECTRUM OF LIGHT SONY CORP (JP) 2018-02-21 EP disclosed
US-9056822-B2 Method for producing polycyclic aromatic compound substituted by aryl group NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2015-06-16 US disclosed
US-20140206908-A1 METHOD FOR PRODUCING POLYCYCLIC AROMATIC COMPOUND SUBSTITUTED BY ARYL GROUP NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2014-07-24 US disclosed
EP-2730554-A1 METHOD FOR PRODUCING POLYCYCLIC AROMATIC COMPOUND SUBSTITUTED BY ARYL GROUP National University Corporation Nagoya University (JP) 2014-05-14 EP disclosed
CN-103709180-A Polycyclic aromatic hydrocarbon derivatives containing imidazoxy [1,2, a] pyridyl group and their use in OLED KUNSHAN VISIONOX DISPLAY TECH 2014-04-09 CN disclosed
US-8574465-B2 Organic polymeric photon up-conversion nanoparticles for biological applications SONY CORPORATION (JP) 2013-11-05 US disclosed
US-20130236555-A1 ORGANIC POLYMERIC PHOTON UP-CONVERSION NANOPARTICLES FOR BIOLOGICAL APPLICATIONS SONY CORPORATION (JP) 2013-09-12 US disclosed
US-8431051-B2 Organic polymeric photon up-conversion nanoparticles for biological applications SONY CORPORATION (JP) 2013-04-30 US disclosed
US-20100301285-A1 POLYMERIC NANOPARTICLES COMPRISING A MEDIUM FOR PHOTON UP-CONVERSION SONY CORPORATION (JP) 2010-12-02 US disclosed
CN-101899295-A Organic polymeric photon up-conversion nanoparticles for biological applications SONY CORP 2010-12-01 CN disclosed
CN-101899184-A The polymeric nanoparticles that comprises medium for photon up-conversion SONY CORP 2010-12-01 CN disclosed
CN-101604107-A Be used to change the device of the wavelength coverage of spectrum SONY CORP (JP) 2009-12-16 CN disclosed
US-20090290211-A1 Device for modifying the wavelength range of a spectrum of light SONY CORPORATION (JP) 2009-11-26 US disclosed
CN-101556421-A A display system SONY CORP (JP) 2009-10-14 CN disclosed
US-20090224659-A1 Display system SONY CORPORATION (JP) 2009-09-10 US disclosed
EP-2075304-A1 A device for modifying the wavelenght range of a spectrum of light Sony Corporation (JP) 2009-07-01 EP disclosed
WO-2009071281-A1 A MEDIUM FOR PHOTON ENERGY UP-CONVERSION SONY CORPORATION (JP) 2009-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130236555-A1 ORGANIC POLYMERIC PHOTON UP-CONVERSION NANOPARTICLES FOR BIOLOGICAL APPLICATIONS UPP1, MKI67, PPOX ALDH1A1 1119/4885HPGD 1090/4885HSD17B10 4804/4885
US-20140206908-A1 METHOD FOR PRODUCING POLYCYCLIC AROMATIC COMPOUND SUBSTITUTED BY ARYL GROUP PAH, DBH, AHR ALDH1A1 2144/4885HPGD 1466/4885HSD17B10 1405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.